Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandklinikken Gilleleje ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   6.7% 5.6% 4.8% 2.1% 1.5% 1.9% 9.5% 9.5%   Credit score (0-100)   37 42 45 65 75 69 26 26   Credit rating   BBB BBB BBB BBB A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.1 7.9 0.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,173 2,738 3,412 3,891 3,676 3,814 0.0 0.0   EBITDA   840 359 979 1,698 1,272 816 0.0 0.0   EBIT   567 225 277 1,602 1,162 726 0.0 0.0   Pre-tax profit (PTP)   469.1 139.3 174.0 1,524.9 1,178.5 740.1 0.0 0.0   Net earnings   364.0 102.1 56.4 1,182.1 912.8 564.6 0.0 0.0   Pre-tax profit without non-rec. items   469 139 174 1,525 1,178 740 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   69.6 23.1 42.1 28.5 0.0 179 0.0 0.0   Shareholders equity total   -39.1 63.0 119 1,302 1,014 679 599 599   Interest-bearing liabilities   180 1,650 1,264 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,155 3,334 2,232 2,121 1,955 1,584 599 599   Net Debt   161 1,647 1,262 -226 -593 -404 -407 -407     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,173 2,738 3,412 3,891 3,676 3,814 0.0 0.0   Gross profit growth   69.5% -13.7% 24.6% 14.1% -5.5% 3.8% -100.0% 0.0%   Employees   3 4 0 0 0 4 0 0   Employee growth %   0.0% 33.3% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,155 3,334 2,232 2,121 1,955 1,584 599 599   Balance sheet change%   35.2% 5.7% -33.1% -5.0% -7.8% -19.0% -62.2% 0.0%   Added value   840.3 359.3 978.5 1,697.5 1,257.4 816.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -548 -263 -765 -191 -221 6 -179 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   17.9% 8.2% 8.1% 41.2% 31.6% 19.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.9% 9.0% 10.0% 74.3% 58.1% 41.9% 0.0% 0.0%   ROI %   36.0% 17.4% 15.3% 104.5% 89.5% 75.6% 0.0% 0.0%   ROE %   13.3% 6.3% 61.8% 166.4% 78.8% 66.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -1.3% 1.9% 5.4% 62.4% 52.0% 43.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   19.1% 458.5% 129.0% -13.3% -46.6% -49.5% 0.0% 0.0%   Gearing %   -460.0% 2,618.0% 1,058.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   13.7% 16.8% 7.1% 14.6% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 1.2 1.4 2.7 2.0 1.4 0.0 0.0   Current Ratio   1.1 1.3 1.4 2.6 2.1 1.4 0.0 0.0   Cash and cash equivalent   19.3 2.6 1.7 226.3 593.4 404.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   218.8 582.5 429.4 1,018.6 827.3 346.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   280 90 0 0 0 204 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   280 90 0 0 0 204 0 0   EBIT / employee   189 56 0 0 0 181 0 0   Net earnings / employee   121 26 0 0 0 141 0 0